Stay informed with the latest litigation news. Explore now

IP Verse

Pyridone Compound As C-Met Inhibitor - EP3533787B1

EP3533787

FUJIAN COSUNTER PHARMACEUTICAL
Application Number
EP17864813A
Filing Date
Oct 27, 2017
Status
Granted And Under Opposition
Aug 28, 2020
Grant Date
Sep 30, 2020
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3533787B1 was granted to Fujian Cosunter Pharmaceutical on Sep 30, 2020 following the initial filing on Oct 27, 2017 under the application number EP17864813A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK PATENTJun 30, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents